Close Menu

NEW YORK (360Dx) – T2 Biosystems announced today that it has closed its previously announced public offering, raising about $52.6 million in gross proceeds.

The firm sold about 7 million shares of its common stock, including 915,000 shares to the offering's underwriters, who exercised in full their option to purchase additional shares at a price of $7.50 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.